Filing Details

Accession Number:
0001181431-12-042325
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-07-26 17:50:33
Reporting Period:
2012-07-24
Filing Date:
2012-07-26
Accepted Time:
2012-07-26 17:50:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1544116 Durata Therapeutics Inc. DRTX Pharmaceutical Preparations (2834) 871247903
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1192212 O. Philippe Chambon C/O New Leaf Ventures
Times Square Tower, 7 Times Square, Ste
New York NY 10036
No No Yes No
1231092 James Niedel C/O New Leaf Ventures
Times Square Tower, 7 Times Square, Ste
New York NY 10036
No No Yes No
1253170 Srinivas Akkaraju C/O New Leaf Ventures
2500 Sand Hill Road, Suite 203
Menlo Park CA 94025
No No Yes No
1340806 K Vijay Lathi C/O New Leaf Ventures
2500 Sand Hill Road, Suite 203
Menlo Park CA 94025
No No Yes No
1441439 New Leaf Ventures Ii, L.p. C/O New Leaf Ventures
Times Square Tower, 7 Times Sq, Ste 3502
New York NY 10036
No No Yes No
1441563 Jeani Delagardelle C/O New Leaf Ventures
2500 Sand Hill Road, Suite 203
Menlo Park CA 94025
No No Yes No
1441857 New Leaf Venture Management Ii, L.l.c. C/O New Leaf Ventures
Times Square Tower, 7 Times Square, Ste
New York NY 10036
No No Yes No
1441858 New Leaf Venture Associates Ii, L.p. C/O New Leaf Ventures
Times Square Tower, 7 Times Square, Ste
New York NY 10036
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-07-24 2,244,126 $0.00 2,244,126 No 4 C Indirect See Footnote
Common Stock Acquisiton 2012-07-24 784,313 $9.00 3,028,439 No 4 P Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect See Footnote
No 4 P Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series A Preferred Stock Disposition 2012-07-24 17,953,008 $0.00 2,244,126 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
Footnotes
  1. All outstanding shares of Series A Preferred Stock were automatically converted into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration.
  2. The securities are directly held by New Leaf Ventures II, L.P. ("NLV II") and indirectly held by New Leaf Venture Associates II, L.P. ("NLV Associates II"), the sole general partner of NLV II, New Leaf Venture Management II, L.L.C. ("NLV Management II"), the sole general partner of NLV Associates II, and the individual managers of NLV Management II (NLV Associates II, NLV Management II and the individual managers of NLV Management II each, an "Indirect Reporting Person"). The individual managers of NLV Management II filing jointly with NLV II, NLV Associates II and NLV Management II are Philippe O. Chambon, James Niedel, Vijay Lathi, Jeani Delagardelle and Srinivas Akkaraju. Each Indirect Reporting Person disclaims beneficial ownership of such portion of the NLV II shares in which such Indirect Reporting Person has no actual pecuniary interest therein.